Yesterday, March 9, 2016, 100 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $6.95 to $910,998,000.00.

Highlighted Stocks Traded by Insiders:

Illumina (ILMN) - FREE Research Report

Dadswell Charles, who is Sr VP & General Counsel at Illumina, sold 8,382 shares at $155.63 on March 9, 2016. Following this transaction, the Sr VP & General Counsel owned 58,241 shares meaning that the stake was reduced by 12.58% with the 8,382-share transaction.

The shares most recently traded at $155.03, down $0.60, or 0.39% since the insider transaction. Historical insider transactions for Illumina go as follows:

  • 4-Week # shares sold: 1,108
  • 12-Week # shares sold: 1,276
  • 24-Week # shares sold: 4,370

The average volume for Illumina has been 1.6 million shares per day over the past 30 days. Illumina has a market cap of $23.8 billion and is part of the health care sector and drugs industry. Shares are down 20.29% year-to-date as of the close of trading on Wednesday.

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company has a P/E ratio of 48.5. Currently, there are 7 analysts who rate Illumina a buy, no analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ILMN - FREE

TheStreet Quant Ratings rates Illumina as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Illumina Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Infoblox (BLOX) - FREE Research Report

Phelps Daniel J, who is Director at Infoblox, sold 3,000 shares at $16.16 on March 9, 2016. Following this transaction, the Director owned 19,500 shares meaning that the stake was reduced by 13.33% with the 3,000-share transaction.

The shares most recently traded at $15.10, down $1.06, or 7.02% since the insider transaction. Historical insider transactions for Infoblox go as follows:

  • 4-Week # shares sold: 29,926
  • 12-Week # shares sold: 29,926
  • 24-Week # shares sold: 51,390

The average volume for Infoblox has been 688,700 shares per day over the past 30 days. Infoblox has a market cap of $967.1 million and is part of the technology sector and telecommunications industry. Shares are down 15.61% year-to-date as of the close of trading on Wednesday.

Infoblox Inc., together with its subsidiaries, designs, develops, manufactures, and sells network control solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Currently, there are 5 analysts who rate Infoblox a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BLOX - FREE

TheStreet Quant Ratings rates Infoblox as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and compelling growth in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full Infoblox Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Access National (ANCX) - FREE Research Report

Taylor Margaret M, who is Executive Vice President, CFO at Access National, bought 79 shares at $18.78 on March 9, 2016. Following this transaction, the Executive Vice President, CFO owned 4,108 shares meaning that the stake was boosted by 1.97% with the 79-share transaction.

The shares most recently traded at $19.03, up $0.25, or 1.31% since the insider transaction. Historical insider transactions for Access National go as follows:

  • 4-Week # shares bought: 983
  • 4-Week # shares sold: 2,910
  • 12-Week # shares bought: 983
  • 12-Week # shares sold: 2,910
  • 24-Week # shares bought: 983
  • 24-Week # shares sold: 2,910

The average volume for Access National has been 26,400 shares per day over the past 30 days. Access National has a market cap of $202.7 million and is part of the financial sector and banking industry. Shares are down 8.85% year-to-date as of the close of trading on Wednesday.

Access National Corporation operates as a bank holding company for Access National Bank that provides credit, deposit, mortgage, and wealth management services to small and medium sized businesses, professionals, and associated individuals primarily in the greater Washington, D.C. The stock currently has a dividend yield of 3.19%. The company has a P/E ratio of 12.9. Currently, there are 2 analysts who rate Access National a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ANCX - FREE

TheStreet Quant Ratings rates Access National as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, increase in net income, solid stock price performance and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Access National Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.